| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,332 |
26,619 |
$2.90M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26,487 |
21,707 |
$1.66M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
21,872 |
18,381 |
$1.01M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
9,424 |
8,362 |
$864K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
4,669 |
4,285 |
$318K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,824 |
4,710 |
$235K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,598 |
5,474 |
$120K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
802 |
746 |
$95K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
810 |
757 |
$90K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,679 |
5,222 |
$60K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
241 |
232 |
$27K |
| 99384 |
|
137 |
125 |
$17K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,233 |
1,987 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
916 |
785 |
$11K |
| 99173 |
|
1,623 |
1,470 |
$11K |
| 90686 |
|
789 |
747 |
$9K |
| 93000 |
|
687 |
582 |
$8K |
| 99383 |
|
51 |
47 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
54 |
50 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
28 |
26 |
$4K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
108 |
95 |
$4K |
| 99385 |
|
26 |
26 |
$4K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
44 |
32 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
869 |
810 |
$3K |
| 69210 |
|
85 |
81 |
$2K |
| 86580 |
|
329 |
291 |
$2K |
| 90662 |
|
79 |
68 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
113 |
106 |
$1K |
| 81025 |
|
157 |
142 |
$857.68 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
44 |
42 |
$738.15 |
| 90715 |
|
42 |
39 |
$613.98 |
| G0008 |
Administration of influenza virus vaccine |
107 |
93 |
$470.26 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
69 |
56 |
$273.92 |
| 81002 |
|
4,439 |
3,996 |
$216.60 |
| 90694 |
|
18 |
17 |
$142.20 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
12 |
$83.56 |
| 3008F |
|
237 |
223 |
$8.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
51 |
44 |
$1.98 |
| 99000 |
|
71 |
68 |
$0.00 |